Overindulging in rich foods while taking a drug like Wegovy or Zepbound can raise the risk of side effects like nausea and ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 ...

Shares of Biogen rose 3% following news of Novo's Alzheimer's trial failure. Biogen and partner Eisai's Leqembi and rival Eli ...

Researchers found benefits including reduced blood pressure were reversed after patients ceased taking the jab ...

Chrissy had a medical reason. The post Chrissy Teigen’s Tragic Reason for Using Weight-Loss Drug appeared first on Reality Tea.

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 ...

Lizzo also reflected on how her coping mechanisms changed during that time. She admitted that the old version of herself ...

In the first quarter of 2018, there were less than five postpartum GLP-1 prescriptions, but by the second quarter of 2022, the number rose to 34 per 10,000 and sharply increased to 173 per 10,000 in ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Novo Nordisk shares tumbled Monday morning after the Danish drugmaker posted the latest results from a drug trial.

Novo Nordisk’s stock is experiencing a steep drop following major clinical setbacks and intensifying competitive pressure in ...

Researchers say a woman struggling with obesity who couldn't resist eating fatty foods experienced declines in her cravings ...